GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cue Health Inc (OTCPK:HLTHQ) » Definitions » Altman Z2-Score

HLTHQ (Cue Health) Altman Z2-Score : -11.82 (As of Apr. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Cue Health Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Cue Health has a Altman Z2-Score of -11.82, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Cue Health's Altman Z2-Score or its related term are showing as below:


Cue Health Altman Z2-Score Historical Data

The historical data trend for Cue Health's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Health Altman Z2-Score Chart

Cue Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
- -1.42 7.54 4.97 -8.72

Cue Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 0.28 -0.70 -8.72 -

Competitive Comparison of Cue Health's Altman Z2-Score

For the Health Information Services subindustry, Cue Health's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cue Health's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cue Health's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Cue Health's Altman Z2-Score falls into.


;
;

Cue Health Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Cue Health's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.1079+3.26*-2.2599+6.72*-1.1383+1.05*2.369
=-11.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $283.66 Mil.
Total Current Assets was $72.05 Mil.
Total Current Liabilities was $41.45 Mil.
Retained Earnings was $-641.05 Mil.
Pre-Tax Income was -49.516 + -148.372 + -42.237 + -83.864 = $-323.99 Mil.
Interest Expense was -0.148 + -0.344 + -0.304 + -0.291 = $-1.09 Mil.
Total Liabilities was $84.20 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(72.046 - 41.445)/283.659
=0.1079

X2=Retained Earnings/Total Assets
=-641.054/283.659
=-2.2599

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-323.989 - -1.087)/283.659
=-1.1383

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(199.463 - 0)/84.196
=2.369

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Cue Health has a Altman Z2-Score of -11.82 indicating it is in Distress Zones.


Cue Health  (OTCPK:HLTHQ) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Cue Health Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Cue Health's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cue Health Business Description

Traded in Other Exchanges
N/A
Address
4980 Carroll Canyon Road, Suite 100, San Diego, CA, USA, 92121
Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point of care, all in a device that fits in the palm of hand. Its Cue Integrated Care Platform consists of multiple hardware, software, and diagnostic components and has been engineered so that it can be directly integrated into existing workflows and on-demand services, such as telemedicine, e-Rx services, and EMR systems.
Executives
T-twelve Holdings, Llc 10 percent owner C/O SIERRA FIDUCIARY SUPPORT SERVICES, 100 WEST LIBERTY ST., SUITE 750, RENO NV 89501
Tup Investments, L.p. 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tarsadia Investments, Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Cp (hlth), Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tfc Manager, Llc 10 percent owner C/O SIERRA FIDUCIARY SUPPORT SERVICES, 100 WEST LIBERTY ST., SUITE 750, RENO NV 89501
Nvga I, Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tccs I, Lp 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Tc Gp, Llc 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Tarsadia Capital, Llc 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Aasim Javed officer: Chief Financial Officer C/O CUE HEALTH INC, 4980 CARROLL CANYON RD SUITE 100, SAN DIEGO CA 92121
Randall E. Pollard officer: Chief Accounting Officer 6229 PINE TREE CT., LONG GROVE IL 60047
Clint Sever officer: Chief Product Officer C/O CUE HEALTH INC., 4980 CARROLL CANYON RD. SUITE 100, SAN DIEGO CA 92121
Sachin H. Jain director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Joshua Ghaim director C/O CUE HEALTH INC., 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA 92121
Kelly P. Day 10 percent owner 865 FIGUEROA STREET, SUITE 700, LOS ANGELES CA 90017